Literature DB >> 8535867

Neurodevelopmental outcome of preterm infants with bronchopulmonary dysplasia.

P H Gray1, Y R Burns, H A Mohay, M J O'Callaghan, D I Tudehope.   

Abstract

The neurodevelopmental outcome of 78 infants with bronchopulmonary dysplasia (BPD) was compared with that of 78 control infants matched for birthweight. To determine the effect of the severity of BPD, 62 infants requiring oxygen at 36 weeks' postmenstrual age (sBPD) were compared with their matched controls. Infants were followed up to 2 years of age, corrected for prematurity, and were classified for neurological impairment, developmental delay, and neurodevelopmental disability. Seventy six (98%) BPD infants and 71 (91%) controls had follow up data available to two years. Neurological impairment, developmental delay, and neurodevelopmental disability occurred more frequently in infants with BPD than in controls but this was not significant. For infants with sBPD, the increased incidence of neurological impairment and definite developmental delay was not significant when compared with the controls, though neurodevelopmental disability occurred more frequently (odds ratio (OR) 3.6: 95% confidence intervals (CI) 1.1-11.8). Predictors of disability in infants with sBPD included periventricular haemorrhage (OR 19.4: 95% CI 4.3-86.6), ventricular dilatation (OR 12.8: 95% CI 2.9-57.3), and sepsis (OR 5.0: 95% CI 1.3-19.4). Adjusting for the presence of these factors, the association between BPD and disability was no longer apparent (OR 0.9: 95% CI 0.2-3.6). The findings suggest that BPD is not independently associated with adverse neurodevelopmental outcome.

Entities:  

Mesh:

Year:  1995        PMID: 8535867      PMCID: PMC2528459          DOI: 10.1136/fn.73.3.f128

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  40 in total

1.  Bronchopulmonary dysplasia: clinical presentation.

Authors:  E Bancalari; G E Abdenour; R Feller; J Gannon
Journal:  J Pediatr       Date:  1979-11       Impact factor: 4.406

Review 2.  Outpatient management and follow-up of bronchopulmonary dysplasia.

Authors:  B L Koops; S H Abman; F J Accurso
Journal:  Clin Perinatol       Date:  1984-02       Impact factor: 3.430

3.  Severe bronchopulmonary dysplasia: a retrospective review.

Authors:  L Mayes; E Perkett; M T Stahlman
Journal:  Acta Paediatr Scand       Date:  1983-03

4.  Observations on bronchopulmonary dysplasia.

Authors:  W H Northway
Journal:  J Pediatr       Date:  1979-11       Impact factor: 4.406

5.  Radiographic aspects of bronchopulmonary dysplasia.

Authors:  D K Edwards
Journal:  J Pediatr       Date:  1979-11       Impact factor: 4.406

6.  Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network.

Authors:  M Hack; J D Horbar; M H Malloy; J E Tyson; E Wright; L Wright
Journal:  Pediatrics       Date:  1991-05       Impact factor: 7.124

7.  Growth and development of very low birthweight infants recovering from bronchopulmonary dysplasia.

Authors:  V Y Yu; A A Orgill; S B Lim; B Bajuk; J Astbury
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

8.  Infants with bronchopulmonary dysplasia. Growth pattern and neurologic and developmental outcome.

Authors:  B R Vohr; E F Bell; W Oh
Journal:  Am J Dis Child       Date:  1982-05

9.  Severe bronchopulmonary dysplasia in the very low birth weight infant: its relationship to developmental outcome.

Authors:  E Goldson
Journal:  J Dev Behav Pediatr       Date:  1984-08       Impact factor: 2.225

10.  Growth and development in children recovering from bronchopulmonary dysplasia.

Authors:  T Markestad; P M Fitzhardinge
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

View more
  6 in total

1.  Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis.

Authors:  Alex G Cuenca; James L Wynn; Kindra M Kelly-Scumpia; Philip O Scumpia; Lizette Vila; Matthew J Delano; Clayton E Mathews; Shannon M Wallet; Westley H Reeves; Kevin E Behrns; Dina C Nacionales; Philip A Efron; Steven L Kunkel; Lyle L Moldawer
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

Review 2.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

Review 3.  Mitochondrial dysfunction in alveolar and white matter developmental failure in premature infants.

Authors:  Vadim S Ten
Journal:  Pediatr Res       Date:  2016-11-03       Impact factor: 3.756

Review 4.  Emerging Clinical Benefits of New-Generation Fat Emulsions in Preterm Neonates.

Authors:  Gregory Guthrie; Muralidhar Premkumar; Douglas G Burrin
Journal:  Nutr Clin Pract       Date:  2017-01-27       Impact factor: 3.080

5.  Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates.

Authors:  J K Trittmann; L D Nelin; M A Klebanoff
Journal:  Eur J Pediatr       Date:  2013-05-05       Impact factor: 3.183

6.  Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study.

Authors:  H Nakanishi; A Uchiyama; S Kusuda
Journal:  J Perinatol       Date:  2016-07-21       Impact factor: 2.521

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.